Core Laboratories Stock Forward View - Relative Strength Index
| CLB Stock | USD 16.28 0.51 3.23% |
Momentum
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth -0.03 | EPS Estimate Next Quarter 0.15 | EPS Estimate Current Year 0.7467 | Wall Street Target Price 15.8333 | EPS Estimate Current Quarter 0.19 |
This section provides headline-driven context for Core Laboratories NV alongside peer activity. Sentiment context here is built from Core Laboratories' options activity and short interest data.
Core Laboratories Short Interest Reading
A sudden spike in Core Laboratories' short interest may indicate that institutional investors have identified specific risks - such as earnings disappointments or regulatory events - not yet priced into the market.
200 Day MA 14.3271 | Short Percent 0.251 | Short Ratio 10.34 | Shares Short Prior Month 4.2 M | 50 Day MA 18.2224 |
RSI Oscillator - Core
Core Laboratories News-to-Price Pattern
Sentiment data for Core Laboratories NV synthesizes media coverage, analyst tone, and social engagement into a single signal. When Core Laboratories' sentiment diverges sharply from price, a mean-reversion trade may be developing.
For Core Laboratories, sentiment analysis reveals whether the prevailing narrative matches business reality. A persistent divergence often resolves in the direction of fundamentals once sentiment normalizes.
Core Laboratories Implied Volatility | 0.97 |
When Core Laboratories' implied volatility is unusually high relative to its historical average, options premiums are inflated. Sophisticated investors may choose to sell options in this environment to collect elevated premium income.
Core Laboratories after-hype prediction price | $ 15.76 |
The sentiment view is a companion to forecasting, technical studies, analyst estimates, and earnings trends.
Use Historical Fundamental Analysis of Core Laboratories to cross-verify projections for Core Laboratories. The view provides historical context for the projection set.Rule 16 for the current Core contract
Based on Rule 16, the market-implied daily move for 2026-06-18 options is about 6.06%. At a recent price around $ 16.28, the implied daily move is approximately $ 0.99 , which is informational only.
Open Interest for Core Options Expiring 2026-06-18
Open interest for Core Laboratories describes outstanding contracts and gives a view of market engagement.
Core Laboratories Additional Predictive Modules
Forecasting Core Laboratories's price movement relies on structured analysis of indicator behavior, momentum signatures, and historical volatility patterns. Time-series models tend to perform better when fed clean, stationary data with consistent periodicity.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Core Laboratories Volatility | Backtest Core Laboratories | Information Ratio |
Core Laboratories Trading Date Momentum
| On March 17 2026 Core Laboratories NV was traded for 16.27 at the closing time. Highest Core Laboratories's price during the trading hours was 16.27 and the lowest price during the day was 15.76 . There was no trading activity during the period 0.0. Lack of trading volume on the 17th of March 2026 did not affect price variability. The overall trading delta to current price is -3.10% . |
| Compare Core Laboratories to competition |
Other Forecasting Options for Core Laboratories
For both new and experienced investors in Core, the ability to analyze Core Laboratories' price movement is a fundamental investment skill. Price chart noise in Core Stock can create false signals and mislead investment decisions.Core Laboratories Related Equities
The following equities are related to Core Laboratories within the Energy space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Core Laboratories against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Core Laboratories Market Strength Events
Tracking market strength indicators for Core Laboratories helps investors understand the momentum dynamics of the stock in real time. These signals support informed decisions about when to enter or exit positions in Core Laboratories NV for maximum return potential.
Core Laboratories Risk Indicators
Properly assessing Core Laboratories' risk indicators is a prerequisite for building reliable price forecasts. Identifying and quantifying the risks associated with Core Laboratories' allows investors to make better-informed decisions about accepting or hedging their exposure.
| Mean Deviation | 1.69 | |||
| Standard Deviation | 2.34 | |||
| Variance | 5.47 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Core Laboratories
A coverage review of Core Laboratories NV helps investors see when the security is attracting above-average attention from contributors and market observers. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Core Laboratories Short Properties
A short-interest review of Core Laboratories NV helps investors understand whether skepticism in the market is becoming more influential. This is most valuable when investors want to know whether bearish pressure is starting to shape the market's reaction function.
| Common Stock Shares Outstanding | 46.5 M | |
| Cash And Short Term Investments | 22.8 M |
More Resources for Core Stock Analysis
A structured review of Core Laboratories often starts with core financial statements and trend context. Ratio analysis helps investors evaluate Core Laboratories NV Stock operating efficiency and financial trajectory. Highlighted below are reports that provide context for Core Laboratories NV Stock:Use Historical Fundamental Analysis of Core Laboratories to cross-verify projections for Core Laboratories. The view provides historical context for the projection set. With Core Laboratories showing P/E 101.74 and ROE 12.1%, investors get more value when this analysis is combined with the diversification and construction tools below. That valuation within Energy invites comparison with Oil & Gas Equipment & Services peers using the tools below to judge whether the multiple is justified. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Quarterly Earnings Growth -0.03 | Dividend Share 0.04 | Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.07 |
Understanding Core Laboratories includes distinguishing between market value and book value, where book value reflects Core's accounting equity. Core Laboratories' market capitalization is 739.52 M. Core Laboratories P/B of 2.62 shows the market assigns a modest premium over accounting equity. Enterprise value stands at 875.48 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Core Laboratories' intrinsic value and market price are different measures derived from different inputs. For Core Laboratories, key inputs include a P/E ratio of 101.74, a P/B ratio of 2.62, a profit margin of 6.04%, and ROE of 12.1%. Core Laboratories market price reflects the current exchange level formed by active bids and offers.